These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7554433)

  • 1. Use of differentiated cholinergic and second messenger endpoints to evaluate cholinesterase inhibitors.
    Blusztajn JK; Davis RO
    Clin Exp Pharmacol Physiol; 1995 May; 22(5):368-9. PubMed ID: 7554433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP.
    Dettbarn WD; Yang ZP; Milatovic D
    Chem Biol Interact; 1999 May; 119-120():445-54. PubMed ID: 10421482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oximes and atropine upon the development of delayed neurotoxic signs in chickens following poisoning by DFP and sarin.
    Davies DR; Holland P
    Biochem Pharmacol; 1972 Dec; 21(23):3145-51. PubMed ID: 4650636
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative seizure inducing properties of various cholinesterase inhibitors: antagonism by diazepam and midazolam.
    Domino EF
    Neurotoxicology; 1987; 8(1):113-22. PubMed ID: 3561897
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicity of DFP and related compounds to squids in relation to cholinesterase inhibition and detoxifying enzyme levels.
    Dettbarn WD; Hoskin FC
    Bull Environ Contam Toxicol; 1975 Feb; 13(2):133-40. PubMed ID: 1125437
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds.
    Hong MS; Hong SJ; Barhoumi R; Burghardt RC; Donnelly KC; Wild JR; Venkatraj V; Tiffany-Castiglioni E
    Toxicol Appl Pharmacol; 2003 Jan; 186(2):110-8. PubMed ID: 12639502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative non-cholinergic neurotoxic effects of paraoxon and diisopropyl fluorophosphate (DFP) on human neuroblastoma and astrocytoma cell lines.
    Qian Y; Venkatraj J; Barhoumi R; Pal R; Datta A; Wild JR; Tiffany-Castiglioni E
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):162-71. PubMed ID: 17223147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
    Yang ZP; Dettbarn WD
    Biochem Pharmacol; 1998 May; 55(9):1419-26. PubMed ID: 10076534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of the effect of diazepam on acetylcholine concentration in mouse brain].
    Tonkopiĭ VD; Sofronov GA; Aleksandriĭskaia IE; Brestkina LM
    Biull Eksp Biol Med; 1978; 86(7):38-40. PubMed ID: 678649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Finding cholinesterase in endotheliocytes: cholinesterase inhibition by organophosphorus compounds leads to endotheliocyte deformation].
    Prozorovskiĭ VB; Skopichev VG
    Eksp Klin Farmakol; 2005; 68(3):64-7. PubMed ID: 16047685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of phenelzine on the toxicity of cholinergic drugs modified by reserpine].
    Liebmann H; Matthies H; Kumbier E
    Acta Biol Med Ger; 1971; 26(3):551-8. PubMed ID: 5148320
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of organophosphorus compounds with muscarinic receptors in SH-SY5Y human neuroblastoma cells.
    Ehrich M; Intropido L; Costa LG
    J Toxicol Environ Health; 1994 Sep; 43(1):51-63. PubMed ID: 8078092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
    Wu SY; Casida JE
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.
    Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
    Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):51-60. PubMed ID: 7737042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of dopamine and GABA in neurotoxicity of organophosphorus cholinesterase inhibitors.
    Ho IK; Fernando JC; Sivam SP; Hoskins B
    Proc West Pharmacol Soc; 1984; 27():177-80. PubMed ID: 6494152
    [No Abstract]   [Full Text] [Related]  

  • 16. Organophosphate-induced convulsions and prevention of neuropathological damages.
    Tuovinen K
    Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro reactivation kinetics of paraoxon- and DFP-inhibited electric eel AChE using mono- and bis-pyridinium oximes.
    Gupta B; Sharma R; Singh N; Kuca K; Acharya JR; Ghosh KK
    Arch Toxicol; 2014 Feb; 88(2):381-90. PubMed ID: 24065055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of triphenylphosphite and diisopropyl phosphorofluoridate on catecholamine secretion from bovine adrenomedullary chromaffin cells.
    Knoth-Anderson J; Abou-Donia MB
    J Toxicol Environ Health; 1993 Feb; 38(2):103-14. PubMed ID: 8433396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endogenous acetylcholine on spontaneous activity in rat dorsal cochlear nucleus slices.
    Chen K; Waller HJ; Godfrey DA
    Brain Res; 1998 Feb; 783(2):219-26. PubMed ID: 9507142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of acetylcholine in brain and blood of animals poisoned with cholinesterase inhibitors.
    STEWART WC
    Br J Pharmacol Chemother; 1952 Jun; 7(2):270-6. PubMed ID: 14954125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.